Wave Life Sciences Ltd’s recent filing unveils that its Director TAKANASHI KEN unloaded Company’s shares for reported $42630.0 on Aug 05 ’25. In the deal valued at $8.75 per share,4,872 shares were sold. As a result of this transaction, TAKANASHI KEN now holds 5,716,303 shares worth roughly $48.3 million.
Then, Tan Aik Na sold 1,127 shares, generating $9,861 in total proceeds. Upon selling the shares at $8.75, the Director now owns 14,988 shares.
Before that, Verdine Gregory L. sold 30,000 shares. Wave Life Sciences Ltd shares valued at $208,500 were divested by the Director at a price of $6.95 per share. As a result of the transaction, Verdine Gregory L. now holds 282,517 shares, worth roughly $2.39 million.
Canaccord Genuity initiated its Wave Life Sciences Ltd [WVE] rating to a Buy in a research note published on August 04, 2025; the price target was $19. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who began to cover the stock in late July with a ‘”an Outperform”‘ rating. Citigroup began covering WVE with “Buy” recommendation on July 16, 2025.
Price Performance Review of WVE
On Tuesday, Wave Life Sciences Ltd [NASDAQ:WVE] saw its stock jump 4.26% to $8.45. Over the last five days, the stock has lost -4.41%. Wave Life Sciences Ltd shares have risen nearly 47.21% since the year began. Nevertheless, the stocks have fallen -31.69% over the past one year. While a 52-week high of $16.74 was reached on 01/03/25, a 52-week low of $5.04 was recorded on 04/09/25.
Levels Of Support And Resistance For WVE Stock
The 24-hour chart illustrates a support level at 8.24, which if violated will result in even more drops to 8.03. On the upside, there is a resistance level at 8.59. A further resistance level may holdings at 8.73.
How much short interest is there in Wave Life Sciences Ltd?
A steep rise in short interest was recorded in Wave Life Sciences Ltd stocks on 2025-07-31, growing by 0.28 million shares to a total of 16.08 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 15.8 million shares. There was a rise of 1.73%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on April 29, 2025 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating along with a $10 price target.
